RVL Pharmaceuticals plc Profit Margin

RVL Pharmaceuticals plc (RVLP) currently reports a profit margin of -184.91% as of June 2023. That compares with -161.69% in the prior-year period — down 14.4% year over year. That is below the Healthcare sector average of 14.34%. Use the charts on this page to explore RVL Pharmaceuticals plc's profit margin history and peer comparisons.

RVL Pharmaceuticals plc's profit margin decreased from -161.69% to -184.91% — a 14.4% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

RVL Pharmaceuticals plc's profit margin of -184.91% is lower than the Healthcare sector average of 14.34%. That is roughly 1389.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but RVL Pharmaceuticals plc's current -184.91% should be judged against Healthcare norms (sector average: 14.34%) and against RVLP's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -184.91%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for RVL Pharmaceuticals plc, and consider following RVLP for alerts when major investors trade the stock.